Responsiveness of the inhaled corticosteroid questionnaire (ICQ): a patient self-reported side effect scale Source: Eur Respir J 2006; 28: Suppl. 50, 208s Year: 2006
Reproducibility and patient acceptability of the inhaled corticosteroid questionnaire (ICQ): a patient self-reported side effect scale Source: Eur Respir J 2006; 28: Suppl. 50, 207s Year: 2006
The inhaled corticosteroids questionnaire shortened version (ICQ-S): A brief patient-rated scale for monitoring inhaled corticosteroid side effects in clinical practice Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012
Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021
Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV1 predict treatment failure during hospitalisation due to COPD exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 525s Year: 2007
Changes in COPD symptom control questionnaire (CCQ) scores after seven days of treatment with prednisolone of acute exacerbations in hospitalised patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 54s Year: 2003
Relationship between pulmonary function and satisfaction with inhaled asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 285s Year: 2004
Validation of a diagnosis-agnostic symptom questionnaire for asthma and/or COPD Source: ERJ Open Res, 7 (1) 00828-2020; 10.1183/23120541.00828-2020 Year: 2021
Oral corticosteroids in asthma exacerbations: Differences between patient-reported data and proxies from claims data Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016
Clinical COPD questionnaire (CCQ) score and mortality Source: Annual Congress 2011 - COPD diagnosis Year: 2011
Validity and reliability of the symptom domain of the clinical COPD questionnaire (CCQ) Source: Eur Respir J 2006; 28: Suppl. 50, 807s Year: 2006
Correlation between indices of quality of life and degree of severity of symptoms in patients with asthma in combination with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 520s Year: 2004
Patients‘ beliefs about inhaled corticosteroids (ICS): relationship with adherence Source: Annual Congress 2008 - Social determinants and psychological issues in primary care respiratory diseases Year: 2008
Satisfaction with asthma treatment questionnaire, (SATQ) Source: Eur Respir J 2002; 20: Suppl. 38, 203s Year: 2002
The effect of smoking on severity of asthma and quality of life in patients treated with inhaled corticosteroids and long-acting b2-agonist (ICS/LABA) Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Satisfaction with inhaled asthma medication and patients quality of life Source: Eur Respir J 2004; 24: Suppl. 48, 285s Year: 2004
Comparison of diagnostic value of patient health questionnaire 9 (PHQ-9) and Beck depression inventory (BDI) questionnaire for preliminary diagnosing of depression in COPD patients (pts) Source: International Congress 2014 – COPD markers Year: 2014
Is the asthma control questionnaire (ACQ) usefull during acute moderate to severe (AMS) asthma exacerbations (AE)? Source: Eur Respir J 2004; 24: Suppl. 48, 591s Year: 2004
Asthma control questionnaire score (ACQ-5) predicts future risk of exacerbations Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009
Measures to assess adherence to inhaled corticosteroids for asthma Source: Eur Respir J 2003; 22: Suppl. 45, 294s Year: 2003